During the summer months of 2021, community transmission rates of COVID-19 have again surged across the U.S. People with chronic lymphocytic leukemia (CLL) and other blood cancers, who are immunocompromised, face added risk from COVID-19 and need more information on vaccine and booster shot efficacy.

In this episode, Gwen Nichols, MD, Chief Medical Officer, the Leukemia & Lymphoma Society (LLS), explains how patients are helping researchers discover these answers through participation in the LLS National Patient Registry and the far-reaching effects their participation will have on improving care for patients with blood cancer. 

Guest: Gwen Nichols, MD

Chief Medical Officer

The Leukemia & Lymphoma Society (LLS)

Related Content

• Returning to Practice in the Post-COVID-19 Era: Resources for Treating Chronic Lymphocytic Leukemia
• [PODCAST] Ep 61: CLL Patient Education in Transitional Times
• [PODCAST] Ep 57: COVID-19 Challenges: Managing Patients with CLL
• [WEBINAR] Learning from COVID-19: Coping Strategies for CLL Providers & Patients
• [WEBINAR] Plain & Simple: Strategies for Improving Health Literacy
• Leukemia & Lymphoma Society (LLS)
• LLS National Patient Registry
• A study from The Leukemia & Lymphoma Society shows COVID-19 vaccine is safe but 25% of blood cancer patients do not produce detectable antibodies. Read the full paper published in Cancer Cell here. 
• COVID-19 vaccine safety among blood cancer patients
• COVID-19 vaccine FAQ for patients and caregivers